p90RSKs mediate the activation of ribosomal RNA synthesis by the hypertrophic agonist phenylephrine in adult cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 59, Issue , 2013, Pages 139-147

  Zhang, Ze ^a   Liu, Rui ^a   Townsend, Paul A ^b   Proud, Christopher G ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cardiomyocyte; Hypertrophy; MAP kinase; p90RSK; Ribosome biogenesis

Indexed keywords

BID 1870; DNA DIRECTED RNA POLYMERASE; DNA DIRECTED RNA POLYMERASE III; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLEPHRINE; PROTEIN RSK P90; PROTEIN SERINE THREONINE KINASE INHIBITOR; RAPAMYCIN; RIBOSOME RNA; S6 KINASE; SL 0101; UNCLASSIFIED DRUG; TARGET OF RAPAMYCIN KINASE;

ADULT; ANIMAL CELL; ARTICLE; CARDIAC MUSCLE CELL; CELL STIMULATION; CHEMICAL LABELING; ENZYME ACTIVATION; HEART HYPERTROPHY; MEK ERK SIGNALING; NONHUMAN; PRIORITY JOURNAL; RAT; RIBOSOMAL RNA SYNTHESIS; RNA SYNTHESIS; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; ANIMAL; CARDIOMEGALY; CHEMICALLY INDUCED DISORDER; CHROMATIN IMMUNOPRECIPITATION; DRUG EFFECT; GENETICS; HEART MUSCLE CELL; MALE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIOMEGALY; CHROMATIN IMMUNOPRECIPITATION; MALE; MYOCYTES, CARDIAC; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA, RIBOSOMAL; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84875643640     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.03.006     Document Type: Article

References (55)

1. Hannan, R.D., Jenkins, A., Jenkins, A.K., Brandenburger, Y., Cardiac hypertrophy: a matter of translation. Clin Exp Pharmacol Physiol 30 (2003), 517–527.
2. Wang, L., Proud, C.G., Ras/Erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor agonists in adult cardiomyocytes. Circ Res 91 (2002), 821–829.
3. Wang, L., Gout, I., Proud, C.G., Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways. MEK-dependent activation of S6K2 in cardiomyocytes. J Biol Chem 276 (2001), 32670–32677.
4. Wang, L., Proud, C.G., Regulation of the phosphorylation of elongation factor 2 by MEK-dependent signalling in adult rat cardiomyocytes. FEBS Lett 531 (2002), 285–289.
5. Wang, L., Proud, C.G., Regulation of the phosphorylation of elongation factor 2 by MEK-dependent signalling in adult rat cardiomyocytes. FEBS Lett 531 (2002), 285–289.
6. Rolfe, M., McLeod, L.E., Pratt, P.F., Proud, C.G., Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2). Biochem J 388 (2005), 973–984.
7. Morgan, H.E., Siehl, D., Chua, B.H., Lautensack-Belser, N., Faster protein and ribosome synthesis in hypertrophying heart. Basic Res Cardiol 80:Suppl. 2 (1985), 115–118.
8. Morgan, H.E., Gordon, E.E., Kira, Y., Chua, B.H.L., Russo, L.A., Peterson, C.J., et al. Biochemical mechanisms of cardiac hypertrophy. Annu Rev Physiol 49 (1987), 533–543.
9. Mayer, C., Grummt, I., Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 25 (2006), 6384–6391.
10. Kantidakis, T., Ramsbottom, B.A., Birch, J.L., Dowding, S.N., White, R.J., mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1. Proc Natl Acad Sci U S A 107 (2010), 11823–11828.
11. Michels, A.A., Robitaille, A.M., Buczynski-Ruchonnet, D., Hodroj, W., Reina, J.H., Hall, M.N., et al. mTORC1 directly phosphorylates and regulates human MAF1. Mol Cell Biol 30 (2010), 3749–3757.
12. Goodfellow, S.J., Innes, F., Derblay, L.E., MacLellan, W.R., Scott, P.H., White, R.J., Regulation of RNA polymerase III transcription during hypertrophic growth. EMBO J 25 (2006), 1522–1533.
13. Wang, Y., Huang, B.P.H., Luciani, D.S., Wang, X., Johnson, J.D., Proud, C.G., Rheb activates protein synthesis and growth in adult rat ventricular cardiomyocytes. J Mol Cell Cardiol 45 (2008), 812–820.
14. Romeo, Y., Zhang, X., Roux, P.P., Regulation and function of the RSK family of protein kinases. Biochem J 441 (2012), 553–569.
15. i. Am J Physiol 36 (1994), H1759–H1769.
16. Wang, L., Wang, X., Proud, C.G., Activation of mRNA translation in rat cardiac myocytes by insulin involves multiple rapamycin-sensitive steps. Am J Physiol Heart Circ Physiol 278 (2000), H1056–H1068.
17. Iadevaia, V., Zhang, Z., Jan, E., Proud, C.G., mTOR signaling regulates the processing of pre-rRNA in human cells. Nucleic Acids Res 40 (2012), 2527–2539.
18. del SB, Valdes R., Mata, J., Felipe, A., Casado, F.J., Pastor-Anglada, M., Differential expression and regulation of nucleoside transport systems in rat liver parenchymal and hepatoma cells. Hepatology 28 (1998), 1504–1511.
19. Duflot, S., Riera, B., Fernandez-Veledo, S., Casado, V., Norman, R.I., Casado, F.J., et al. ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors. Mol Cell Biol 24 (2004), 2710–2719.
20. Cleary, M.D., Meiering, C.D., Jan, E., Guymon, R., Boothroyd, J.C., Biosynthetic labeling of RNA with uracil phosphoribosyltransferase allows cell-specific microarray analysis of mRNA synthesis and decay. Nat Biotechnol 23 (2005), 232–237.
21. Woodford, T.A., Schlegel, R., Pardee, A.B., Selective isolation of newly synthesized mammalian mRNA after in vivo labeling with 4-thiouridine or 6-thioguanosine. Anal Biochem 171 (1988), 166–172.
22. Mann, J., Chu, D.C., Maxwell, A., Oakley, F., Zhu, N.L., Tsukamoto, H., et al. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 138 (2010), 705–714 [714].
23. Poortinga, G., Hannan, K.M., Snelling, H., Walkley, C.R., Jenkins, A., Sharkey, K., et al. MAD1 and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation. EMBO J 23 (2004), 3325–3335.
24. Brandenburger, Y., Jenkins, A., Autelitano, D.J., Hannan, R.D., Increased expression of UBF is a critical determinant for rRNA synthesis and hypertrophic growth of cardiac myocytes. FASEB J 15 (2001), 2051–2053.
25. Brandenburger, Y., Arthur, J.F., Woodcock, E.A., Du, X.J., Gao, X.M., Autelitano, D.J., et al. Cardiac hypertrophy in vivo is associated with increased expression of the ribosomal gene transcription factor UBF. FEBS Lett 548 (2003), 79–84.
26. Huang, M., Wang, Y., Cogut, S.B., Mitchell, B.S., Graves, L.M., Inhibition of nucleoside transport by protein kinase inhibitors. J Pharmacol Exp Ther 304 (2003), 753–760.
27. Baldwin, S.A., Beal, P.R., Yao, S.Y., King, A.E., Cass, C.E., Young, J.D., The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 447 (2004), 735–743.
28. Pende, M., Um, S.H., Mieulet, V., Sticker, M., Goss, V.L., Mestan, J., et al. S6K1(−/−)/S6K2(−/−) mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 24 (2004), 3112–3124.
29. Yeh, T.C., Marsh, V., Bernat, B.A., Ballard, J., Colwell, H., Evans, R.J., et al. Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor. Clin Cancer Res 13 (2007), 1576–1583.
30. Sapkota, G.P., Cummings, L., Newell, F.S., Armstrong, C., Bain, J., Frodin, M., et al. BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem J 401 (2007), 29–38.
31. Jastrzebski, K., Hannan, K.M., Tchoubrieva, E.B., Hannan, R.D., Pearson, R.B., Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function. Growth Factors 25 (2007), 209–226.
32. Feldman, M.E., Apsel, B., Uotila, A., Loewith, R., Knight, Z.A., Ruggero, D., et al. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol, 7, 2009, e38.
33. Wang, X., Beugnet, A., Murakami, M., Yamanaka, S., Proud, C.G., Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol Cell Biol 25 (2005), 2558–2572.
34. Thoreen, C.C., Kang, S.A., Chang, J.W., Liu, Q., Zhang, J., Gao, Y., et al. An ATP-competitive mTOR inhibitor reveals rapamycin-insensitive functions of mTORC1. J Biol Chem 284 (2009), 8023–8032.
35. Choo, A.Y., Yoon, S.O., Kim, S.G., Roux, P.P., Blenis, J., Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci U S A 105 (2008), 17414–17419.
36. Hoppe, S., Bierhoff, H., Cado, I., Weber, A., Tiebe, M., Grummt, I., et al. AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply. Proc Natl Acad Sci U S A 106 (2009), 17781–17786.
37. Dokladda, K., Green, K.A., Pan, D.A., Hardie, D.G., PD98059 and U0126 activate AMP-activated protein kinase by increasing the cellular AMP:ATP ratio and not via inhibition of the MAP kinase pathway. FEBS Lett 579 (2005), 236–240.
38. Moore, C.E., Xie, J., Gomez, E., Herbert, T.P., Identification of cAMP-dependent kinase as a third in vivo ribosomal protein S6 kinase in pancreatic beta-cells. J Mol Biol 389 (2009), 480–494.
39. Sebolt-Leopold, J.S., Dudley, D.T., Herrera, R., Becelaere, K.V., Wiland, A., Gowan, R.C., et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med 5 (1999), 810–816.
40. Anjum, R., Blenis, J., The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9 (2008), 747–758.
41. Fonseca, B.D., Alain, T., Finestone, L.K., Huang, B.P., Rolfe, M., Jiang, T., et al. Pharmacological and genetic evaluation of proposed roles of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK), extracellular signal-regulated kinase (ERK), and p90RSK in the control of mTORC1 protein signaling by phorbol esters. J Biol Chem 286 (2011), 27111–27122.
42. Amirak, E., Fuller, S.J., Sugden, P.H., Clerk, A., p90 ribosomal S6 kinases play a significant role in early gene regulation in the cardiomyocyte response to Gq protein-coupled receptor stimuli, endothelin-1 and alpha1-adrenergic receptor agonists. Biochem J 450 (2012), 351–363.
43. Chen, S., MacKintosh, C., Differential regulation of NHE1 phosphorylation and glucose uptake by inhibitors of the ERK pathway and p90RSK in 3T3-L1 adipocytes. Cell Signal 21 (2009), 1984–1993.
44. Smith, J.A., Poteet-Smith, C.E., Xu, Y., Errington, T.M., Hecht, S.M., Lannigan, D.A., Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer Res 65 (2005), 1027–1034.
45. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C.J., McLauchlan, H., et al. The selectivity of protein kinase inhibitors: a further update. Biochem J 408 (2007), 297–315.
46. Zhao, J., Yuan, X., Frodin, M., Grummt, I., ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth. Mol Cell 11 (2003), 405–413.
47. Ballif, B.A., Roux, P.P., Gerber, S.A., Mackeigan, J.P., Blenis, J., Gygi, S.P., Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors. Proc Natl Acad Sci U S A 102 (2005), 667–672.
48. Carriere, A., Cargnello, M., Julien, L.A., Gao, H., Bonneil, E., Thibault, P., et al. Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation. Curr Biol 18 (2008), 1269–1277.
49. Roux, P.P., Ballif, B.A., Anjum, R., Gygi, S.P., Blenis, J., Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci U S A 101 (2004), 13489–13494.
50. Li, T., Liu, Z., Hu, X., Ma, K., Zhou, C., Involvement of ERK-RSK cascade in phenylephrine-induced phosphorylation of GATA4. Biochim Biophys Acta 2012 (1823), 582–592.
51. Allo, S.N., McDermott, P.J., Carl, L.L., Morgan, H.E., Phorbol ester stimulation of protein kinase C activity and ribosomal DNA transcription. Role in hypertrophic growth of cultured cardiomyocytes. J Biol Chem 266 (1991), 22003–22009.
52. McDermott, P.J., Rothblum, L.I., Smith, S.D., Morgan, H.E., Accelerated rates of ribosomal RNA synthesis during growth of contracting heart cells in culture. J Biol Chem 264 (1989), 18220–18227.
53. Avkiran, M., Cook, A.R., Cuello, F., Targeting Na +/H + exchanger regulation for cardiac protection: a RSKy approach?. Curr Opin Pharmacol 8 (2008), 133–140.
54. Kilic, A., Javadov, S., Karmazyn, M., Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy. J Mol Cell Cardiol 46 (2009), 360–369.
55. Li, J., Kritzer, M.D., Michel, J.J., Le, A., Thakur, H., Gayanilo, M., et al. Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy. Circ Res 112 (2013), 128–139.